ACIU
AC Immune Ltd
2.70$
+0.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 60.3% | 68.5% | 65.7% | 76.0% | 76.8% | 74.5% | 72.1% | 69.3% | 66.3% | 62.7% | 58.3% | 62.1% | |
| 22.3% | 42.9% | 34.1% | 21.7% | 13.3% | 15.7% | 9.5% | 13.5% | 16.2% | 17.4% | 13.9% | 18.5% | |
| 55.9% | 56.4% | 62.7% | 73.7% | 64.6% | 71.7% | 69.0% | 66.8% | 63.2% | 59.3% | 54.4% | 50.1% | |
| 0.2% | 8.2% | 0.2% | 0.2% | 10.4% | 0.5% | 0.4% | 0.3% | 0.2% | 0.7% | 0.2% | 9.1% | |
| -0.3% | -0.3% | -0.5% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | 36.7% | – | |
| 35.3% | 27.6% | 30.1% | 21.2% | 20.6% | 21.8% | 23.9% | 26.5% | 29.4% | 32.7% | – | 33.5% | |
| 12.1% | 12.1% | 13.5% | 48.0% | 46.7% | 51.4% | 55.1% | 60.7% | 63.6% | 70.9% | 77.1% | 76.6% | |
| 8.2% | 7.4% | 8.4% | 42.3% | 41.3% | 43.7% | 47.0% | 52.0% | 57.3% | 61.4% | 67.1% | 66.6% | |
| 0.4% | 0.4% | 0.4% | 0.3% | 0.3% | 0.4% | 0.5% | 0.5% | 0.6% | 0.6% | 0.6% | 0.6% | |
| 1.0% | 0.9% | 1.7% | 0.6% | 0.6% | 1.2% | 1.1% | 1.4% | 0.9% | 1.3% | 1.0% | 1.0% | |
| 87.9% | 87.9% | 86.5% | 52.0% | 53.3% | 48.6% | 44.9% | 39.3% | 36.4% | 29.1% | 22.9% | 23.4% | |
| -217.1% | -173.0% | -198.8% | -149.3% | -142.9% | -159.5% | -183.0% | -213.9% | -244.6% | -284.6% | -329.5% | -299.5% | |
| 58.8% | 46.0% | 59.4% | 41.9% | 41.3% | 43.7% | 47.6% | 52.9% | 57.8% | 65.5% | 71.8% | 65.6% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.